Humana (HUM) said late Wednesday it agreed with a consortium of investors to sell all of its minority interest in hospice and palliative care services provider Gentiva.
Humana's stake was valued at $900 million, according to a statement.
Proceeds will be used for general corporate purposes, the company said.
The deal is expected to be completed in Q3, subject to closing conditions, it added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.